Handelsavisen
prelaunch
Companies ›Financials ›CD2.AX
CD
CD2.AX — ASX Investment Management & Fund Operators

Cd2.Ax

A$0,33
Open in Charts → Attach watcher ⌖
— —
AUD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
19,9M AUD
P/E
—
EV / Rev
—
Div yield
—
Op margin
81,0 %
ROE
0,3 %
Net margin
5,5 %
Debt / equity
0,00
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

CD2.AX operates in the investment management and fund operators industry, providing banking and investment services to its clients.

Business. CD2.AX operates in the investment management and fund operators industry, providing banking and investment services to its clients.

Classification92 %
SectorFinancials
Business sectorBanking & Investment Services
IndustryInvestment Management & Fund Operators
ActivityBanking & Investment Services
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
0,3 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CD2.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CD2.AX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    CD2.AX operates in the investment management and fund operators industry, providing banking and investment services to its clients.

    Classification92 %
    SectorFinancials
    Business sectorBanking & Investment Services
    IndustryInvestment Management & Fund Operators
    ActivityBanking & Investment Services
    AI synthesis
    GENERATED

    CD2.AX has a market price of 0.38 and a market cap of 19942052.68, indicating a relatively small capitalization. The company's price-to-earnings ratio is 95.99, which is significantly higher than the typical range for the industry, suggesting that the stock may be overvalued relative to its earnings. The price-to-book ratio is 0.27, and the price-to-tangible-book ratio is also 0.27, indicating that the company's market value is much lower than its book value.

    In terms of profitability, CD2.AX has a return on equity of 0.0029 and a return on assets of 0.0026, which are both very low. These figures suggest that the company is not generating significant returns for its shareholders or effectively utilizing its assets. The company's operating income is 3063320.0, and its net income is 207760.0, indicating that while the company is profitable, its net income is a small fraction of its operating income.

    CD2.AX's revenue is 3782330.0, and its gross profit is 3334290.0, suggesting that the company has a high gross margin. However, the company's operating cash flow is -2248560.0, indicating a negative cash flow from operations, which could be a concern for its liquidity. The company's total assets are 79153570.0, and its total liabilities are 6347600.0, resulting in a current ratio of 45.41, which is very high and suggests that the company has a strong liquidity position.

    The company's growth trajectory is not clearly defined, as there is no specific data on revenue growth or future projections. However, the company's current financial position, with a high current ratio and low debt-to-equity ratio, suggests that it has a strong balance sheet and is not heavily leveraged. The company's liquidity position is considered low, and there are no immediate filing-based liquidity or dilution flags, indicating that the company is not currently facing significant financial risks.

    Recent events and filings do not indicate any significant changes or risks for CD2.AX. The company's financial statements do not show any major issues, and there are no immediate concerns regarding liquidity or dilution. The company's financial position appears to be stable, with a strong liquidity position and a low debt-to-equity ratio.

    Key takeaways
    • CD2.AX has a high current ratio of 45.41, indicating a strong liquidity position.
    • The company's return on equity and return on assets are very low, suggesting poor profitability.
    • The company's price-to-earnings ratio is significantly higher than typical industry levels, indicating potential overvaluation.
    • CD2.AX has a negative operating cash flow, which could be a concern for its liquidity.
    • The company's financial position is stable, with no immediate liquidity or dilution flags.
    • **margin_outlook_rationale**: The company's gross margin is high, but its operating margin is low, indicating potential inefficiencies in operations.
    • **rd_outlook_rationale**: There is no specific data on the company's research and development activities or future outlook.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    A$0,33
    Market cap
    A$19.9M
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    0.3x
    P / Tangible bookⓘ
    0.3x
    Tangible book
    A$72.8M
    Net cashⓘ
    —
    Current ratioⓘ
    45.4
    Debt / equityⓘ
    0.0
    ROAⓘ
    0.3%
    ROEⓘ
    0.3%
    Cash conversionⓘ
    -1082.0%
    CapEx / revenueⓘ
    —
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin81,0 %Above P75
    Net Margin5,5 %Below median
    ROE0,3 %Below median
    D/E0,00Above median
    Cash Conv-10,82Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • CD2.AX Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CD2.AXCanonical
    ASX · AUD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage